High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Tumor Dissemination: An EMT Affair

(2013) Jean Paul Thiery et al.   CANCER CELL

High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients

(2012) Chih-Jung Chen et al.   CLINICA CHIMICA ACTA

A Novel Five Gene Signature Derived from Stem-Like Side Population Cells Predicts Overall and Recurrence-Free Survival in NSCLC

(2012) Deepak Perumal et al.   PLoS One

Gender Difference in the Prognostic Role of Interleukin 6 in Oral Squamous Cell Carcinoma

(2012) Chih-Jung Chen et al.   PLoS One

Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers

(2011) S. J. Kim et al.   ANNALS OF ONCOLOGY

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

(2011) E C M Zeestraten et al.   BRITISH JOURNAL OF CANCER

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

(2011) S. Ogino et al.   CLINICAL CANCER RESEARCH

A Polymorphic −844T/C inFasLPromoter Predicts Survival and Relapse in Non–Small Cell Lung Cancer

(2011) Wen-Wei Sung et al.   CLINICAL CANCER RESEARCH

Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance

(2011) Chunyu Zhang et al.   PLoS One

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients

(2009) J G H van Nes et al.   BRITISH JOURNAL OF CANCER

Cdc2 as prognostic marker in stage UICC II colon carcinomas

(2009) Alexander Meyer et al.   EUROPEAN JOURNAL OF CANCER